2 projects
Core technology underpinning both SNIFFPHONE (breath-based disease screening) and INISH MINI-BAR (on-site bacteria detection in beer).
Organization
CELLIX LIMITED
Irish microfluidics SME building portable diagnostic platforms for rapid disease detection and food safety testing.
Technology SMEhealthIESMENo active H2020 projects
H2020 projects
3
As coordinator
1
Total EC funding
€1.8M
Unique partners
22
What they do
Their core work
Cellix is an Irish SME that develops microfluidic devices and lab-on-chip platforms for rapid, on-site diagnostic testing. Their core technology enables miniaturized sensor-based screening — from detecting diseases through exhaled breath to identifying bacterial contamination in beverages. They bridge the gap between laboratory-grade analytical tools and portable, field-deployable detection systems, serving both healthcare and food safety markets.
Core expertise
What they specialise in
Biosensor and rapid diagnosticsprimary
3 projects
All three projects — SNIFFPHONE, INISH MINI-BAR, and TAPAS — involve sensor-based biological detection or cell-level analysis.
Point-of-care disease detectionsecondary
2 projects
SNIFFPHONE targeted gastric cancer screening from breath, and TAPAS focused on platelet adhesion in thrombosis research.
Food safety testingsecondary
1 project
INISH MINI-BAR (coordinated by Cellix) developed rapid on-site bacteria detection directly from beer taps.
Cell adhesion and flow-based assaysemerging
1 project
TAPAS project involved platelet adhesion research, suggesting expansion into cardiovascular diagnostics.
Evolution & trajectory
How they've shifted over time
Early focus
Breath-based disease diagnostics
Recent focus
Biomedical cell analysis
Cellix's H2020 journey began with sensor-heavy diagnostics work — nanotechnology-enabled breath analysis for gastric cancer detection (SNIFFPHONE, 2015). They then applied their microfluidics expertise to food safety, coordinating their own SME Instrument project for rapid bacteria detection in beer (INISH MINI-BAR, 2017). Their most recent involvement (TAPAS, 2018-2022) moved into blood cell research and thrombosis, indicating a broadening from diagnostics into fundamental biomedical applications.
Cellix appears to be expanding from portable diagnostics into deeper biomedical research applications, which could position them for clinical and pharmaceutical partnerships.
Collaboration profile
How they like to work
Role: specialist_contributorReach: European10 countries collaborated
Cellix operates flexibly — they have coordinated their own SME Instrument project, participated as a technology partner in a larger consortium, and contributed as a third party. With 22 unique partners across 10 countries from just 3 projects, they integrate well into diverse international teams. Their varied roles suggest they are adaptable and willing to contribute their microfluidics expertise in whatever capacity a consortium needs.
Despite only 3 projects, Cellix has built a broad European network of 22 partners across 10 countries, reflecting the large consortium sizes typical of RIA and MSCA projects. Their geographic reach spans well beyond Ireland.
Why partner with them
What sets them apart
Cellix occupies a rare niche: a commercial microfluidics company that can deploy its platform across very different application domains — from healthcare diagnostics to food safety to fundamental biomedical research. Their SME Instrument success (INISH MINI-BAR) shows they can translate lab technology into market-ready products. For consortium builders, they offer a ready-made microfluidic platform that can be adapted to new detection challenges without starting from scratch.
Notable projects
Highlights from their portfolio
- INISH MINI-BARCellix's own coordinated SME Instrument project — demonstrates commercial ambition with a concrete product for on-site bacteria detection in the brewing industry.
- SNIFFPHONEAmbitious multi-partner project combining smartphone technology with nanosensors for non-invasive gastric cancer screening from breath — Cellix contributed microfluidics expertise.
Cross-sector capabilities
Food safety and quality controlNanotechnology and sensor developmentDigital health and portable diagnosticsBeverage industry quality assurance
More in Health & Biomedical
See all Health & Biomedical organizations →KOBENHAVNS UNIVERSITET
Denmark's largest research university, excelling in genomics, CRISPR, microbiome science, ancient DNA, and climate research across 696 H2020 projects.
Open →
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France's national biomedical research agency — 400+ H2020 projects spanning neuroscience, infectious disease, cancer, and omics-driven diagnostics.
Open →
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.
Open →